A @nejm.org editorial today on the Office of White House Management and Budget (OMB) regarding their new funding proposal and politicization of science
www.nejm.org/doi/full/10....
Finally caught up with Borrelia guru, friend and former partner in crime on the rubgy pitch, @bstevensonlab.bsky.social after a (very) long time.
Beers were had 🍺
We need to get a bigger labcoat for next time.
😃
In an unexpected turn of events, the damaged lamp post is pointing at the angry councillor.
www.nwemail.co.uk/news/2617566...
Almost 2️⃣ years in…
Our MANIFEST AGM convened scientists, clinicians, patient partners & industry. Keynotes from Prof Levesque & Prof Rattray + Prof Turajlić setting the course ahead.
Big thank you to all for continuing to believe in the vision; to tackle the hard questions in #CancerImmunotherapy.
Exciting breakthrough technology from the lab, now live in
@cellcellpress.bsky.social
! Instead of cutting the genome where proteins bind (e.g., Cut&Tag), D&D-seq scars the DNA with a deaminase, allowing single cell genome mapping of TFs and chromatin remodellers!
imgflip.com/i/atc3be
Wash cycle complete!
At the Institute for Cancer Research / Royal Marsden Hospital with @generoom.bsky.social
Douglas Adams:
> Anything in the world when you're born is normal, ordinary and a natural part of the world. Anything invented between when you’re 15-35 is new, exciting and revolutionary and you can get a career in it. Anything invented after you're 35 is against the natural order of things.
1/
Two of the most powerful technologies we've ever known—CRISPR human embryo editing and self-improving A.I.—are getting actualized, and carry known and unforeseen risks
nytimes.com/2026/06/04/s...
wsj.com/tech/ai/anth...
@anthropicai.bsky.social
🧬How can #genomics help us uncover cancer's vulnerabilities?
Join us to hear how novel genomic approaches are revealing new insights into #cancer evolution and identifying potential therapeutic targets.
#ConvergingOnCancer International Seminar
📅 2 July, 10-11am BST
